Home › Scleroderma

Scleroderma clinical trials recruiting in the U.S.

31 studies for Scleroderma are recruiting participants at sites across the United States.

Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.

Cities with the most studies

• New York City, NY10 studies
• Ann Arbor, MI9 studies
• Houston, TX8 studies
• Chicago, IL8 studies
• Los Angeles, CA7 studies
• Boston, MA7 studies
• Durham, NC7 studies
• Baltimore, MD6 studies
• Dallas, TX5 studies
• New Orleans, LA5 studies
• Miami, FL5 studies
• Philadelphia, PA5 studies
• Pittsburgh, PA5 studies
• Charleston, SC4 studies
• Washington, DC4 studies
• Kansas City, KS4 studies
• Edison, NJ4 studies
• New Haven, CT4 studies
• San Diego, CA3 studies
• Mountain View, CA3 studies
• St. Louis, MO3 studies
• Cedar Rapids, IA3 studies
• Tucson, AZ3 studies
• Minneapolis, MN3 studies
• Plantation, FL3 studies
• Charlotte, NC3 studies
• Jacksonville, FL3 studies
• Aurora, CO3 studies
• Phoenix, AZ3 studies

By state

• Alabama3 studies
• Arizona5 studies
• California12 studies
• Colorado4 studies
• Connecticut4 studies
• District of Columbia4 studies
• Florida9 studies
• Illinois9 studies
• Iowa3 studies
• Kansas5 studies
• Kentucky3 studies
• Louisiana5 studies
• Maryland6 studies
• Massachusetts7 studies
• Michigan9 studies
• Minnesota5 studies
• Missouri3 studies
• New Jersey5 studies
• New York10 studies
• North Carolina9 studies
• Ohio4 studies
• Pennsylvania9 studies
• South Carolina4 studies
• Tennessee5 studies
• Texas12 studies
• Virginia3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.